NASDAQ:EXEL - Exelixis News Headlines

Sign in or create an account to add this stock to your watchlist.
$19.33 -0.46 (-2.32 %)
(As of 05/19/2019 02:29 AM ET)
Previous Close$19.33
Today's Range$19.26 - $19.81
52-Week Range$13.42 - $25.31
Volume2.83 million shs
Average Volume3.76 million shs
Market Capitalization$5.83 billion
P/E Ratio13.52
Dividend YieldN/A
Beta2.06

Headlines

Exelixis (NASDAQ EXEL) News Headlines

Source:
DateHeadline
Exelixis and Iconic Therapeutics Enter into Exclusive Option and License Agreement for Novel Antibody-Drug Conjugate Program - Yahoo FinanceExelixis and Iconic Therapeutics Enter into Exclusive Option and License Agreement for Novel Antibody-Drug Conjugate Program - Yahoo Finance
finance.yahoo.com - May 16 at 10:02 AM
Exelixis and Iconic Therapeutics Enter into Exclusive Option and License Agreement for Novel Antibody-Drug Conjugate ProgramExelixis and Iconic Therapeutics Enter into Exclusive Option and License Agreement for Novel Antibody-Drug Conjugate Program
finance.yahoo.com - May 16 at 10:02 AM
Reviewing Exelixis (EXEL) & STARPHARMA HOLD/S (SPHRY)Reviewing Exelixis (EXEL) & STARPHARMA HOLD/S (SPHRY)
www.americanbankingnews.com - May 16 at 8:18 AM
Exelixis Announces Webcasts of Investor Conference Presentations on May 21, 2019 - Yahoo FinanceExelixis Announces Webcasts of Investor Conference Presentations on May 21, 2019 - Yahoo Finance
finance.yahoo.com - May 15 at 8:07 AM
Exelixis Announces Webcasts of Investor Conference Presentations on May 21, 2019Exelixis Announces Webcasts of Investor Conference Presentations on May 21, 2019
finance.yahoo.com - May 14 at 8:19 PM
These 3 Value Stocks Are Absurdly Cheap Right Now - Yahoo FinanceThese 3 Value Stocks Are Absurdly Cheap Right Now - Yahoo Finance
finance.yahoo.com - May 14 at 3:16 PM
Daiichi Sankyo launches MINNEBRO tablets in Japan - Seeking AlphaDaiichi Sankyo launches MINNEBRO tablets in Japan - Seeking Alpha
seekingalpha.com - May 13 at 3:14 PM
Exelixis, Inc. (EXEL) Receives Average Rating of "Hold" from AnalystsExelixis, Inc. (EXEL) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 13 at 7:05 AM
$230.96 Million in Sales Expected for Exelixis, Inc. (EXEL) This Quarter$230.96 Million in Sales Expected for Exelixis, Inc. (EXEL) This Quarter
www.americanbankingnews.com - May 11 at 2:24 AM
Insider Selling: Exelixis, Inc. (EXEL) Director Sells 50,000 Shares of StockInsider Selling: Exelixis, Inc. (EXEL) Director Sells 50,000 Shares of Stock
www.americanbankingnews.com - May 10 at 11:14 PM
Exelixis, Inc. (EXEL) Insider Sells $19,580.00 in StockExelixis, Inc. (EXEL) Insider Sells $19,580.00 in Stock
www.americanbankingnews.com - May 10 at 11:14 PM
Exelixis, Inc. (EXEL) Insider Michael Morrissey Sells 42,000 SharesExelixis, Inc. (EXEL) Insider Michael Morrissey Sells 42,000 Shares
www.americanbankingnews.com - May 10 at 11:14 PM
$0.30 Earnings Per Share Expected for Exelixis, Inc. (EXEL) This Quarter$0.30 Earnings Per Share Expected for Exelixis, Inc. (EXEL) This Quarter
www.americanbankingnews.com - May 9 at 4:18 PM
See what the IHS Markit Score report has to say about Exelixis Inc. - Yahoo FinanceSee what the IHS Markit Score report has to say about Exelixis Inc. - Yahoo Finance
finance.yahoo.com - May 8 at 5:31 AM
Where Will Gilead Sciences Spend Its Cash? - Motley FoolWhere Will Gilead Sciences Spend Its Cash? - Motley Fool
www.fool.com - May 7 at 3:17 PM
Exelixis Expands Its Sales - Motley FoolExelixis Expands Its Sales - Motley Fool
www.fool.com - May 7 at 3:17 PM
Exelixis Expands Its SalesExelixis Expands Its Sales
www.fool.com - May 6 at 3:40 PM
Estimating The Fair Value Of Exelixis, Inc. (NASDAQ:EXEL)Estimating The Fair Value Of Exelixis, Inc. (NASDAQ:EXEL)
finance.yahoo.com - May 6 at 3:18 PM
Q3 2019 EPS Estimates for Exelixis, Inc. Increased by Oppenheimer (EXEL)Q3 2019 EPS Estimates for Exelixis, Inc. Increased by Oppenheimer (EXEL)
www.americanbankingnews.com - May 6 at 3:05 AM
Exelixis, Inc. (EXEL) to Post Q2 2019 Earnings of $0.26 Per Share, Piper Jaffray Companies ForecastsExelixis, Inc. (EXEL) to Post Q2 2019 Earnings of $0.26 Per Share, Piper Jaffray Companies Forecasts
www.americanbankingnews.com - May 6 at 2:15 AM
Exelixis, Inc. (EXEL) Expected to Post Q2 2019 Earnings of $0.32 Per ShareExelixis, Inc. (EXEL) Expected to Post Q2 2019 Earnings of $0.32 Per Share
www.americanbankingnews.com - May 6 at 2:13 AM
Q2 2019 Earnings Forecast for Exelixis, Inc. (EXEL) Issued By SunTrust BanksQ2 2019 Earnings Forecast for Exelixis, Inc. (EXEL) Issued By SunTrust Banks
www.americanbankingnews.com - May 6 at 2:13 AM
Edited Transcript of EXEL earnings conference call or presentation 1-May-19 9:00pm GMTEdited Transcript of EXEL earnings conference call or presentation 1-May-19 9:00pm GMT
finance.yahoo.com - May 5 at 5:02 AM
Insider Selling: Exelixis, Inc. (EXEL) CFO Sells 36,261 Shares of StockInsider Selling: Exelixis, Inc. (EXEL) CFO Sells 36,261 Shares of Stock
www.americanbankingnews.com - May 3 at 9:15 PM
George A. Scangos Sells 40,000 Shares of Exelixis, Inc. (EXEL) StockGeorge A. Scangos Sells 40,000 Shares of Exelixis, Inc. (EXEL) Stock
www.americanbankingnews.com - May 3 at 9:15 PM
Exelixis Inc (EXEL) Q1 2019 Earnings Call Transcript - Yahoo FinanceExelixis Inc (EXEL) Q1 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - May 3 at 3:18 PM
Q2 2019 EPS Estimates for Exelixis, Inc. Raised by Oppenheimer (EXEL)Q2 2019 EPS Estimates for Exelixis, Inc. Raised by Oppenheimer (EXEL)
www.americanbankingnews.com - May 3 at 7:57 AM
Exelixis (EXEL) Releases Quarterly  Earnings Results, Hits ExpectationsExelixis (EXEL) Releases Quarterly Earnings Results, Hits Expectations
www.americanbankingnews.com - May 2 at 10:29 PM
Edited Transcript of EXEL earnings conference call or presentation 1-May-19 9:00pm GMT - Yahoo FinanceEdited Transcript of EXEL earnings conference call or presentation 1-May-19 9:00pm GMT - Yahoo Finance
finance.yahoo.com - May 2 at 3:20 PM
Exelixis Inc (EXEL) Q1 2019 Earnings Call Transcript - Motley FoolExelixis Inc (EXEL) Q1 2019 Earnings Call Transcript - Motley Fool
www.fool.com - May 2 at 3:20 PM
Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1 - Yahoo FinanceExelixis (EXEL) Earnings & Revenues Beat Estimates in Q1 - Yahoo Finance
finance.yahoo.com - May 2 at 3:20 PM
Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1
finance.yahoo.com - May 2 at 3:20 PM
Exelixis (EXEL) Given a $27.00 Price Target by Morgan Stanley AnalystsExelixis (EXEL) Given a $27.00 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - May 2 at 2:47 PM
Exelixis (EXEL) Commences Phase 3 Pivotal Trial (COSMIC-313) of Cabozantinib in Combination with Nivolumab and Ipilimumab - StreetInsider.comExelixis (EXEL) Commences Phase 3 Pivotal Trial (COSMIC-313) of Cabozantinib in Combination with Nivolumab and Ipilimumab - StreetInsider.com
www.streetinsider.com - May 2 at 5:14 AM
Exelixis, Inc. (EXEL) CEO Mike Morrissey on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaExelixis, Inc. (EXEL) CEO Mike Morrissey on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 2 at 5:14 AM
Exelixis (EXEL) Beats Q1 Earnings and Revenue Estimates - Yahoo FinanceExelixis (EXEL) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 2 at 5:14 AM
Exelixis Announces First Quarter 2019 Financial Results and Provides Corporate UpdateExelixis Announces First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 2 at 5:14 AM
Exelixis Initiating Phase 3 Pivotal Trial (COSMIC-313) of Cabozantinib in Combination with Nivolumab and Ipilimumab Versus Nivolumab and Ipilimumab in Previously Untreated Advanced Renal Cell CarcinomaExelixis Initiating Phase 3 Pivotal Trial (COSMIC-313) of Cabozantinib in Combination with Nivolumab and Ipilimumab Versus Nivolumab and Ipilimumab in Previously Untreated Advanced Renal Cell Carcinoma
finance.yahoo.com - May 2 at 5:14 AM
Exelixis: 1Q Earnings SnapshotExelixis: 1Q Earnings Snapshot
finance.yahoo.com - May 2 at 5:14 AM
Exelixis (EXEL) Beats Q1 Earnings and Revenue EstimatesExelixis (EXEL) Beats Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 2 at 5:14 AM
Exelixis Inc (EXEL) Q1 2019 Earnings Call TranscriptExelixis Inc (EXEL) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 2 at 5:14 AM
Exelixis Q1 2019 Earnings Preview - Seeking AlphaExelixis Q1 2019 Earnings Preview - Seeking Alpha
seekingalpha.com - May 1 at 5:13 AM
2 Incredibly Cheap Value Stocks to Buy Now - Motley Fool2 Incredibly Cheap Value Stocks to Buy Now - Motley Fool
www.fool.com - April 29 at 3:12 PM
2 Incredibly Cheap Value Stocks to Buy Now2 Incredibly Cheap Value Stocks to Buy Now
finance.yahoo.com - April 29 at 3:12 PM
Oppenheimer Weighs in on Exelixis, Inc.s FY2020 Earnings (EXEL)Oppenheimer Weighs in on Exelixis, Inc.'s FY2020 Earnings (EXEL)
www.americanbankingnews.com - April 29 at 4:22 AM
Exelixis, Inc. (EXEL) Insider Sells $830,000.00 in StockExelixis, Inc. (EXEL) Insider Sells $830,000.00 in Stock
www.americanbankingnews.com - April 26 at 11:08 PM
Oppenheimer Analysts Cut Earnings Estimates for Exelixis, Inc. (EXEL)Oppenheimer Analysts Cut Earnings Estimates for Exelixis, Inc. (EXEL)
www.americanbankingnews.com - April 26 at 7:40 AM
Exelixis (EXEL) to Report Q1 Earnings: Whats in Store? - Yahoo FinanceExelixis (EXEL) to Report Q1 Earnings: What's in Store? - Yahoo Finance
finance.yahoo.com - April 25 at 3:16 PM
Exelixis’ Partner Takeda Announces Filing of New Drug Application in Japan for CABOMETYX® (Cabozantinib) for Advanced Renal Cell CarcinomaExelixis’ Partner Takeda Announces Filing of New Drug Application in Japan for CABOMETYX® (Cabozantinib) for Advanced Renal Cell Carcinoma
finance.yahoo.com - April 25 at 3:16 PM
Exelixis (EXEL) to Report Q1 Earnings: What's in Store?Exelixis (EXEL) to Report Q1 Earnings: What's in Store?
finance.yahoo.com - April 25 at 3:16 PM
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel